Production of a Covid-19 vaccine potentially worth up to £250 million is under way at a West Lothian plant.Work is already ongoing at Valneva’s premises in Livingston on the £30 million to £50 million first phase of the project, which will save jobs and create up to 50 more.Valneva is a multinational biotech company who develop vaccines for infectious diseases and operate another five sites worldwide.They are currently in discussions with the Coalition for Epidemic Preparedness Innovations (CEPI) to get grant funding for their unique inactivated vaccine.Valneva’s chief financial officer, David Lawrence, confirmed that the phase one production of the liquid vaccine is to be completed at Livingston and that the site is also currently under
Read more on dailyrecord.co.uk